Andrew S. Hodtsev

403 total citations
9 papers, 344 citations indexed

About

Andrew S. Hodtsev is a scholar working on Immunology, Virology and Epidemiology. According to data from OpenAlex, Andrew S. Hodtsev has authored 9 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 5 papers in Virology and 3 papers in Epidemiology. Recurrent topics in Andrew S. Hodtsev's work include T-cell and B-cell Immunology (6 papers), Immune Cell Function and Interaction (6 papers) and HIV Research and Treatment (5 papers). Andrew S. Hodtsev is often cited by papers focused on T-cell and B-cell Immunology (6 papers), Immune Cell Function and Interaction (6 papers) and HIV Research and Treatment (5 papers). Andrew S. Hodtsev collaborates with scholars based in United States. Andrew S. Hodtsev's co-authors include David N. Posnett, Jeffrey Laurence, Shara Kabak, Adam Asch, Steven Friedman, Eugenia Spanopoulou, B C Cole, Yongwon Choi, Mary K. Crow and Joseph R. Tumang and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Andrew S. Hodtsev

9 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew S. Hodtsev United States 7 266 120 80 44 42 9 344
J. Kiss Hungary 11 164 0.6× 132 1.1× 80 1.0× 15 0.3× 109 2.6× 37 350
Brigitte Müllauer Austria 9 234 0.9× 89 0.7× 45 0.6× 12 0.3× 48 1.1× 12 339
Kristina Rothaeusler United States 9 373 1.4× 159 1.3× 129 1.6× 11 0.3× 78 1.9× 11 525
Kelly M. Fahrbach United States 8 99 0.4× 97 0.8× 55 0.7× 44 1.0× 28 0.7× 8 299
A Minassian United States 5 172 0.6× 209 1.7× 115 1.4× 14 0.3× 89 2.1× 6 364
Rebecca LaFond United States 7 308 1.2× 61 0.5× 183 2.3× 17 0.4× 67 1.6× 9 511
Patricia M. Matear United Kingdom 10 209 0.8× 198 1.6× 90 1.1× 10 0.2× 67 1.6× 11 403
S. Rowland-Jones United Kingdom 7 352 1.3× 128 1.1× 93 1.2× 6 0.1× 81 1.9× 14 444
Marie‐France Huguet France 13 238 0.9× 186 1.6× 139 1.7× 12 0.3× 106 2.5× 24 449
Huifeng Yu United States 12 285 1.1× 213 1.8× 95 1.2× 20 0.5× 81 1.9× 17 497

Countries citing papers authored by Andrew S. Hodtsev

Since Specialization
Citations

This map shows the geographic impact of Andrew S. Hodtsev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew S. Hodtsev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew S. Hodtsev more than expected).

Fields of papers citing papers by Andrew S. Hodtsev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew S. Hodtsev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew S. Hodtsev. The network helps show where Andrew S. Hodtsev may publish in the future.

Co-authorship network of co-authors of Andrew S. Hodtsev

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew S. Hodtsev. A scholar is included among the top collaborators of Andrew S. Hodtsev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew S. Hodtsev. Andrew S. Hodtsev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Hodtsev, Andrew S., Yongwon Choi, Eugenia Spanopoulou, & David N. Posnett. (1998). Mycoplasma Superantigen Is a CDR3-dependent Ligand for the T Cell Antigen Receptor. The Journal of Experimental Medicine. 187(3). 319–327. 45 indexed citations
2.
Posnett, David N., et al.. (1995). The HIV-1 reservoir in distinct V? subsets of CD4 T cells: evidence for a putative superantigen. Journal of Clinical Immunology. 15(S6). S18–S21. 3 indexed citations
3.
Kabak, Shara, Kapil Mehta, Chang‐Hee Suh, et al.. (1995). Human immunodeficiency virus 1 reservoir in CD4+ T cells is restricted to certain V beta subsets.. Proceedings of the National Academy of Sciences. 92(12). 5563–5567. 16 indexed citations
4.
Bhardwaj, Nina, Andrew S. Hodtsev, Shara Kabak, et al.. (1994). Human T-cell responses to Mycoplasma arthritidis-derived superantigen. Infection and Immunity. 62(1). 135–144. 17 indexed citations
5.
Posnett, David N., Andrew S. Hodtsev, Shara Kabak, et al.. (1993). Interaction of Mycoplasma arthritidis Superantigen with Human T Cells. Clinical Infectious Diseases. 17(Supplement_1). S170–S175. 6 indexed citations
6.
Posnett, David N., et al.. (1993). T-cell antigen receptor Vβ subsets are not preferentially deleted in AIDS. AIDS. 7(5). 625–632. 54 indexed citations
7.
Laurence, Jeffrey, Andrew S. Hodtsev, & David N. Posnett. (1993). Superantigens in Infectious Diseases, Including AIDS. Annals of the New York Academy of Sciences. 685(1). 746–755. 8 indexed citations
8.
Laurence, Jeffrey, Andrew S. Hodtsev, & David N. Posnett. (1992). Superantigen implicated in dependence of HIV-1 replication in T cells on TCR V β expression. Nature. 358(6383). 255–259. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026